Technology Intelligence
The scientific edge in
emerging technology investment
Innovation Lens provides technology intelligence to VCs and institutional investors on the emerging technologies that will define the next decade, grounded in the latest research from leading labs worldwide.
98%
Quarterly start dates beat SPY (backtested, 2010–2026)
6.5%
Median yearly alpha vs. SPY (backtested)
3,700+
Technology predictions tracked
15+ yr
Verified prediction history
Backtested, hypothetical results. Past performance does not guarantee future results.
What We Do
Intelligence before consensus
We translate the frontier of scientific research into technology intelligence years before it reaches mainstream market awareness.
Deep Scientific Monitoring
We continuously track published and unpublished research in computer science, physics, and biomedicine — identifying breakthroughs before they surface in earnings calls or analyst reports.
Quantified Predictions
Each research signal is assigned a confidence score that measures alignment with commercial applications. In backtested simulations, high-confidence predictions have outperformed market benchmarks over the period studied.
Research for Investors
We partner with venture capital firms, family offices, and institutional investors to identify which emerging technologies merit attention before the crowd arrives.
How It Works
We map the scientific landscape and predict what rises
Our system embeds millions of papers into a unified research landscape, grouping them by semantic proximity across disciplines. We then identify papers our model believes will drive future commercial breakthroughs and mark them as predictions. The maps below show what happens when we overlay predictions made in 2018-2021 with articles published in 2022-2026. On the left, all published articles. On the right, all articles that received at least 300 citations. The same clusters remain, showing our model reliably points to work that goes on to matter most.
Every topic our model predicted as significant during 2018-2021, overlaid on the published research landscape of 2022-2026. Orange dots show our predictions.
Filtering to show only those papers that received 300 or more citations, the clusters hold. Our predictions disproportionately capture the research that becomes most impactful.
Each hexagonal cell represents a distinct research topic cluster. Orange dots are topics and papers flagged by our prediction model prior to citation accumulation.
Scientific Rigor
Research-grounded conviction
Our predictions are not based on market sentiment or analyst reports. They are derived from systematic analysis of primary scientific literature, including papers from the world's leading research institutions that have not yet reached commercial awareness.
Literature Ingestion at Scale
We process tens of millions of preprints and peer-reviewed papers across disciplines, identifying technology-commercialization signals before they enter the mainstream narrative.
Multi-Domain Synthesis
Breakthroughs rarely emerge from a single discipline. We connect dots across computer science, physics, and biomedicine to identify convergence opportunities.
Verified Prediction History
Every prediction is dated, recorded, and scored, creating an auditable track record that speaks for itself.
Private Markets
Our edge multiplies in private markets
If our predictions generate alpha in liquid public markets — where prices reflect millions of participants — imagine the advantage in pre-IPO companies where information asymmetry is far greater and pricing is far less efficient.
Earlier Signal Capture
We identify technology themes 3–7 years before they reach public market consensus, precisely the window where private equity returns are made.
Unpriced Scientific Moats
Private companies often have deep ties to academic research. We identify which scientific relationships translate into durable competitive advantages.
Portfolio Construction Clarity
We help VCs answer: “Is this technical thesis actually grounded in the state of science?” — a question that separates category leaders from also-rans.
Work With Us
Ready to invest at the frontier?
We work with a small number of investment partners. If you are a VC, family office, or institutional investor seeking a durable scientific edge, we would like to speak with you.